Blueprint Medicines Corp announced on June 2, 2025, that it has entered into a merger agreement with Sanofi, where shareholders will receive $129.00 per share plus contingent value rights upon achieving certain milestones.
AI Assistant
BLUEPRINT MEDICINES CORP
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.